Latest Licensing News

Aura Energy has locked in a commercially proven processing flowsheet for its Tiris Uranium Project and signed a non-binding MOU with a major nuclear utility, aiming for a binding agreement and Final Investment Decision by year-end 2026.

Acrux Limited’s FY26 receipts soared 960% to $5 million, fuelled by licensing milestones and growing generic sales, while FDA guidance clears the way for pivotal Phase III trials of its Female Testosterone therapy.

archTIS surged to a record FY2026 with Annual Recurring Revenue hitting $14.8 million, driven by major US and Australian Defence wins and expanding its customer base beyond defence.

Theta Gold Mines has locked in a US$90 million senior secured bond and raised US$18.6 million in equity, pushing its TGME Gold Project construction steadily towards first gold in early 2027.

Meteoric Resources has completed a Definitive Feasibility Study for its Caldeira Rare Earth Project in Brazil, revealing a large, high-grade ionic clay deposit with a 20-plus year mine life and strong financial metrics.

Aspermont Limited reported a 25% year-on-year revenue increase to A$4.5 million in Q3 FY26, achieving normalised EBITDA breakeven for the first time and marking its 40th consecutive quarter of subscription growth. The company’s Data & Intelligence platform advances with key contracts underway and non-subscription revenues surging.

Mesoblast delivered US$115 million in Ryoncil® revenue in its first full year post-FDA approval, while expanding clinical trials into adult indications and acquiring cutting-edge CAR technology to boost its cell therapy pipeline.

Cann Group reported its second-ever quarterly operating cash inflow of $0.24 million in Q4 FY2026, edging closer to cash flow break-even. The company expanded exports to the UK and Germany, launched new products, and completed a leadership transition while redeeming convertible notes and securing additional credit.

Connected Minerals has secured shareholder and regulatory approvals to acquire Frontier Group, gaining an 80% stake in Angola’s Bailundo Carbonatite Project with expanded mineral rights including niobium and rare earths. Completion is imminent as exploration activities ramp up.

Clever Culture Systems has doubled its large pharmaceutical customer base to eight, installed 34 APAS Independence instruments, and expects FY27 sales growth driven by existing and new customers. The company maintains a $1.7 million cash balance, raised $1.6 million in short-term debt, and is expanding validation services.

Resouro Strategic Metals has filed a comprehensive NI 43-101 Technical Report that underpins its Preliminary Economic Assessment for the Tiros Titanium and Rare Earths Project in Brazil, confirming robust economics and a capital-efficient staged development strategy.

dorsaVi has confirmed its RRAM memory and neuromorphic IP operate synergistically, projecting up to 10x performance gains for robotics and exoskeletons. The company also finalized its first integrated RRAM-CMOS validation chip design, advancing towards tape-out and commercialisation.